Tamsulosin
More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia
ATC Code: G04CA02
Side effects
Options: Show MedDRA Preferred Terms, display all 37 labels
| Side effect | Data for drug | Placebo | Labels | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | |||
| Headache | postmarketing — 0.4% - 21.1% | 0.6% - 20.1% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Dizziness | postmarketing — 1.3% - 17.1% | 0.9% - 17.1% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
| Rhinitis | postmarketing — 11.6% - 17.9% | 6.9% - 17.9% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Infection | 4.51% - 10.8% | 4.49% - 7.51% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Abnormal ejaculation | postmarketing, 0.6% - 18.1% | 0% - 18.1% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
| Asthenia | postmarketing — 0.7% - 8.54% | 0.6% - 8.54% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Pain | 7.6% | 7.3% | x | x | ||||||||||||||||||
| Back pain | 6.2% - 8.33% | 4.5% - 8.33% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Diarrhoea | postmarketing — 4.27% - 6.2% | 4.27% - 4.46% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Pharyngitis | 4.3% - 5.8% | 3.9% - 5.08% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Infestation NOS | 4.51% - 5.56% | 4.49% | x | |||||||||||||||||||
| Ejaculation disorder | common | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Gastrointestinal disorder | 3.89% - 4.8% | 1.97% | x | x | x | |||||||||||||||||
| Chest pain | 0.5% - 4.07% | 0.3% - 4.07% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Dyspepsia | 3.8% | 5.4% | x | x | ||||||||||||||||||
| Breast disorder | 3.33% - 3.95% | 0.562% | x | x | ||||||||||||||||||
| Nervous system disorder | 3.06% - 4.09% | 2.53% | x | x | x | |||||||||||||||||
| Abdominal pain | 3.4% | 4.3% | x | x | ||||||||||||||||||
| Cough increased | 3.1% - 4.47% | 2.4% - 4.47% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Arthralgia | 3% | 3.3% | x | x | ||||||||||||||||||
| Somnolence | 2.5% - 4.27% | 1.5% - 4.27% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Mediastinal disorder | postmarketing, 2.78% - 2.82% | 0.843% | x | x | x | |||||||||||||||||
| Nausea | postmarketing — 2.59% - 3.86% | 2.9% - 3.86% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Insomnia | 1.42% - 2.4% | 0.6% - 1.42% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Cardiac disorder | 2.22% - 2.26% | 2.25% | x | x | x | |||||||||||||||||
| Sinusitis | 2.1% - 3.66% | 1.3% - 3.66% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Angiopathy | 2.12% | 2.25% | x | x | x | |||||||||||||||||
| Influenza | 2.1% | 2.9% | x | x | ||||||||||||||||||
| Accidental injury | 2.1% | 3% | x | x | ||||||||||||||||||
| Connective tissue disorder | 1.69% - 2.5% | 1.97% | x | |||||||||||||||||||
| Myalgia | 1.7% | 2.1% | x | |||||||||||||||||||
| Urinary tract infection | 1.5% | 0.4% | x | x | ||||||||||||||||||
| Dysuria | 1.2% | 1.3% | x | x | ||||||||||||||||||
| Erectile dysfunction | 1.2% | 1.5% | x | x | x | |||||||||||||||||
| Tooth disorder | 1.1% - 2.03% | 0.9% - 2.03% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Arthritis | 1.1% | 1% | x | x | ||||||||||||||||||
| Lung disorder | 1.1% | 0.9% | x | x | ||||||||||||||||||
| Hypertonia | 1.1% | 1.5% | x | x | ||||||||||||||||||
| Sweating | 1.1% | 0.8% | x | x | ||||||||||||||||||
| Neck pain | 1% | 1.1% | x | x | ||||||||||||||||||
| Body temperature increased | 1% | 1% | x | |||||||||||||||||||
| Libido decreased | 0.996% - 2.03% | 0.9% - 2.03% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Hypertension | 0.9% | 1.1% | x | x | ||||||||||||||||||
| Oedema peripheral | 0.8% | 1% | x | x | ||||||||||||||||||
| Chills | 0.7% | 1% | x | |||||||||||||||||||
| Congenital genitourinary abnormality | 0.6% | 0% | x | x | x | |||||||||||||||||
| Paraesthesia | 0.4% | 1.1% | x | x | ||||||||||||||||||
| Malaise | 0.4% | 1.1% | x | x | ||||||||||||||||||
| Orthostatic hypotension | postmarketing, uncommon | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |
| Vision blurred | postmarketing, 0.199% - 2.03% | 0.406% - 2.03% | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Angioedema | postmarketing, rare | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Arrhythmia | postmarketing | x | x | x | x | x | x | x | x | x | ||||||||||||
| Atrial fibrillation | postmarketing | x | x | x | x | x | x | x | x | x | ||||||||||||
| Constipation | postmarketing — 1.3% | 1.4% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |
| Dermatitis exfoliative | postmarketing | x | x | |||||||||||||||||||
| Dyspnoea | postmarketing, 1.1% | 1.1% | x | x | x | x | x | x | x | x | x | x | x | |||||||||
| Epistaxis | postmarketing | x | x | |||||||||||||||||||
| Erythema multiforme | postmarketing | x | x | |||||||||||||||||||
| Rash | postmarketing — 1.8% | 1.8% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |
| Hypersensitivity | postmarketing | x | ||||||||||||||||||||
| Hypotension | postmarketing | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Miosis | postmarketing | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Palpitations | postmarketing, uncommon | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |
| Priapism | very rare, postmarketing | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Pruritus | postmarketing — 1% | 1% | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |
| Stevens-Johnson syndrome | postmarketing | x | x | x | x | x | x | x | x | x | ||||||||||||
| Syncope | postmarketing, rare | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Tachycardia | postmarketing | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Urticaria | postmarketing, uncommon | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Disorder sight | postmarketing | x | ||||||||||||||||||||
| Vomiting | postmarketing, uncommon | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Cataract | postmarketing | x | x | |||||||||||||||||||
| Unspecified disorder of skin and subcutaneous tissue | postmarketing | x | x | x | ||||||||||||||||||
| Skin exfoliation | postmarketing | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Reaction gastrointestinal | postmarketing | x | ||||||||||||||||||||
| Intraoperative floppy iris syndrome | postmarketing | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Visual impairment | postmarketing | x | x | |||||||||||||||||||
| Amblyopia | x | x | ||||||||||||||||||||
| Common cold | x | x | x | |||||||||||||||||||
| Cough | x | x | x | |||||||||||||||||||
| Fatigue | x | x | ||||||||||||||||||||
| Seasonal allergy | x | x | x | |||||||||||||||||||
| Nasal congestion | x | x | x | x | x | |||||||||||||||||
| Nasal obstruction | x | x | ||||||||||||||||||||
| Shock | x | x | ||||||||||||||||||||
| Loss of consciousness | x | |||||||||||||||||||||
| Vertigo | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Fever chills | x | |||||||||||||||||||||
| Sinus congestion | x | x | x | |||||||||||||||||||
| Malnutrition | x | x | ||||||||||||||||||||
| Lightheadedness | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
| Ejaculation delayed | x | x | ||||||||||||||||||||
| Dizziness postural | x | x | ||||||||||||||||||||
| Blood pressure systolic decreased | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Blood pressure diastolic decreased | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
| Ejaculation failure | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Influenza-like symptoms | x | x | x | |||||||||||||||||||
| Retrograde ejaculation | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
| Dizziness aggravated | x | x | ||||||||||||||||||||
| Drug interaction | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
| Hypotension orthostatic symptomatic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||||
| Dizzy spells | x | x | ||||||||||||||||||||
| Rhinorrhoea | x | x | x | |||||||||||||||||||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
